HPV Prevention and Control Board: Difference between revisions
New article on HPV Prevention and Control Board - an independent advisory group of international experts that disseminates information on Human Papillomavirus (HPV) vaccine |
(No difference)
|
Revision as of 21:26, 14 October 2020
 | This article or section is in a state of significant expansion or restructuring. You are welcome to assist in its construction by editing it as well. If this article or section has not been edited in several days, please remove this template. If you are the editor who added this template and you are actively editing, please be sure to replace this template with {{in use}} during the active editing session. Click on the link for template parameters to use.
This article was last edited by Whispyhistory (talk | contribs) 3 years ago. (Update timer) |
The HPV Prevention and Control Board is an independent advisory group of international experts that disseminates information on Human Papillomavirus (HPV) vaccine.[1] It was founded in 2015 to deal with emerging challenges in the control and prevention of (HPV) infection and its associated diseases. The Board co-ordinates interactions between people related to HPV control and prevention, provides a forum for discussion where one does not already exist. It advises local policy-makers on starting and expanding HPV vaccination programmes and helps with political commitment necessary for their implementation.[2][3]
It is one of several Regional and global partnerships[4][5] and its website is a member of the WHO-led project Vaccine Safety Net (VSN).[6]
References
- ^ Vorsters, Alex; Bosch, Francesc Xavier; Bonanni, Paolo; Franco, Eduardo L.; Baay, Marc; Simas, Clarissa; Waheed, Dur-e-Nayab; Castro, Carlos; Murillo, Raul; Trujillo, Lina; Wiesner, Carolina (2020-06-22). "Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report". BMC Proceedings. 14 (Suppl 9). doi:10.1186/s12919-020-00192-2. ISSN 1753-6561. PMC 7307134. PMID 32577128.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ Stanley, Margaret; Poljak, Mario (2017-03-16). "Prospects for the new HPV Prevention and Control Board". Papillomavirus Research. 3: 97. doi:10.1016/j.pvr.2017.01.005. ISSN 2405-8521. PMC 5883206. PMID 28720464.
- ^ "Overcoming barriers in HPV vaccination and screening programs". Papillomavirus Research. 4: 45–53. 2017-12-01. doi:10.1016/j.pvr.2017.07.001. ISSN 2405-8521.
- ^ Wittet, Scott; Aylward, Jenny; Cowal, Sally; Drope, Jacqui; Franca, Etienne; Goltz, Sarah; Kuo, Taona; Larson, Heidi; Luciani, Silvana; Mugisha, Emmanuel; Schocken, Celina (July 2017). "Advocacy, communication, and partnerships: Mobilizing for effective, widespread cervical cancer prevention". International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics. 138 Suppl 1: 57–62. doi:10.1002/ijgo.12189. ISSN 1879-3479. PMID 28691332.
- ^ Hawkes, Nigel (16 October 2018). "Lead author of Cochrane HPV review did not breach conflicts policy, find arbiters". British Medical Journal. 363.
- ^ "WHO | HPV Prevention and Control Board". WHO. Retrieved 2020-10-13.